Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1951 1
1954 3
1955 1
1957 1
1960 1
1964 1
1966 1
1987 1
1988 1
1992 1
1995 1
1996 2
1997 1
1998 2
1999 1
2000 4
2001 2
2002 2
2003 3
2004 1
2005 6
2006 2
2007 6
2008 5
2009 6
2010 11
2011 7
2012 10
2013 16
2014 13
2015 9
2016 9
2017 8
2018 7
2019 6
2020 8
2021 11
2022 12
2023 18
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

186 results

Results by year

Filters applied: . Clear all
Page 1
Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial.
Diaz-Manera J, Kishnani PS, Kushlaf H, Ladha S, Mozaffar T, Straub V, Toscano A, van der Ploeg AT, Berger KI, Clemens PR, Chien YH, Day JW, Illarioshkin S, Roberts M, Attarian S, Borges JL, Bouhour F, Choi YC, Erdem-Ozdamar S, Goker-Alpan O, Kostera-Pruszczyk A, Haack KA, Hug C, Huynh-Ba O, Johnson J, Thibault N, Zhou T, Dimachkie MM, Schoser B; COMET Investigator Group. Diaz-Manera J, et al. Among authors: haack ka. Lancet Neurol. 2021 Dec;20(12):1012-1026. doi: 10.1016/S1474-4422(21)00241-6. Lancet Neurol. 2021. PMID: 34800399 Clinical Trial.
Safety and efficacy of avalglucosidase alfa in individuals with infantile-onset Pompe disease enrolled in the phase 2, open-label Mini-COMET study: The 6-month primary analysis report.
Kishnani PS, Kronn D, Brassier A, Broomfield A, Davison J, Hahn SH, Kumada S, Labarthe F, Ohki H, Pichard S, Prakalapakorn SG, Haack KA, Kittner B, Meng X, Sparks S, Wilson C, Zaher A, Chien YH; Mini-COMET Investigators. Kishnani PS, et al. Among authors: haack ka. Genet Med. 2023 Feb;25(2):100328. doi: 10.1016/j.gim.2022.10.010. Epub 2022 Dec 21. Genet Med. 2023. PMID: 36542086 Free article. Clinical Trial.
Arsenic Exposure, Blood DNA Methylation, and Cardiovascular Disease.
Domingo-Relloso A, Makhani K, Riffo-Campos AL, Tellez-Plaza M, Klein KO, Subedi P, Zhao J, Moon KA, Bozack AK, Haack K, Goessler W, Umans JG, Best LG, Zhang Y, Herreros-Martinez M, Glabonjat RA, Schilling K, Galvez-Fernandez M, Kent JW Jr, Sanchez TR, Taylor KD, Johnson WC, Durda P, Tracy RP, Rotter JI, Rich SS, Van Den Berg D, Kasela S, Lappalainen T, Vasan RS, Joehanes R, Howard BV, Levy D, Lohman K, Liu Y, Fallin MD, Cole SA, Mann KK, Navas-Acien A. Domingo-Relloso A, et al. Among authors: haack k. Circ Res. 2022 Jul 8;131(2):e51-e69. doi: 10.1161/CIRCRESAHA.122.320991. Epub 2022 Jun 6. Circ Res. 2022. PMID: 35658476 Free PMC article.
Smoking, blood DNA methylation sites and lung cancer risk.
Domingo-Relloso A, Joehanes R, Rodriguez-Hernandez Z, Lahousse L, Haack K, Fallin MD, Herreros-Martinez M, Umans JG, Best LG, Huan T, Liu C, Ma J, Yao C, Jerolon A, Bermudez JD, Cole SA, Rhoades DA, Levy D, Navas-Acien A, Tellez-Plaza M. Domingo-Relloso A, et al. Among authors: haack k. Environ Pollut. 2023 Oct 1;334:122153. doi: 10.1016/j.envpol.2023.122153. Epub 2023 Jul 11. Environ Pollut. 2023. PMID: 37442331 Free PMC article.
History of social psychiatry.
Haack K, Kumbier E. Haack K, et al. Curr Opin Psychiatry. 2012 Nov;25(6):492-6. doi: 10.1097/YCO.0b013e3283590509. Curr Opin Psychiatry. 2012. PMID: 22992550 Review.
Arsenic Exposure and Epigenetic Aging: The Association with Cardiovascular Disease and All-Cause Mortality in the Strong Heart Study.
Jiang EX, Domingo-Relloso A, Abuawad A, Haack K, Tellez-Plaza M, Fallin MD, Umans JG, Best LG, Zhang Y, Kupsco A, Belsky DW, Cole SA, Navas-Acien A. Jiang EX, et al. Among authors: haack k. Environ Health Perspect. 2023 Dec;131(12):127016. doi: 10.1289/EHP11981. Epub 2023 Dec 22. Environ Health Perspect. 2023. PMID: 38133959 Free PMC article.
[History of neurology in the GDR: a systematic review].
Armbruster J, Grothe M, Haack K, Kumbier E. Armbruster J, et al. Among authors: haack k. Nervenarzt. 2022 Dec;93(12):1250-1257. doi: 10.1007/s00115-022-01354-7. Epub 2022 Jul 12. Nervenarzt. 2022. PMID: 35821436 Free PMC article. Review. German.
Effect of avalglucosidase alfa on disease-specific and general patient-reported outcomes in treatment-naïve adults with late-onset Pompe disease compared with alglucosidase alfa: Meaningful change analyses from the Phase 3 COMET trial.
Toscano A, Pollissard L, Msihid J, van der Beek N, Kishnani PS, Dimachkie MM, Berger KI, DasMahapatra P, Thibault N, Hamed A, Zhou T, Haack KA, Schoser B. Toscano A, et al. Among authors: haack ka. Mol Genet Metab. 2024 Feb;141(2):108121. doi: 10.1016/j.ymgme.2023.108121. Epub 2023 Dec 27. Mol Genet Metab. 2024. PMID: 38184428 Free article. Clinical Trial.
186 results